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INTRODUCTION  
 1
INTRODUCTION 
 
In Sanskrit, tuberculosis (TB) is known as “Rajyachhyama” or “the 
king of diseases”. It is one of the world’s most serious infectious threats.  
Tuberculosis is the second most common cause of death from infectious 
diseases at the global level, being second only to HIV/AIDS1.  
Tuberculosis in children is an important problem especially in countries 
like India where adult tuberculosis is common. 
Globally it has been estimated that 1.9 billion people are infected 
with tuberculosis and 5000 people die of TB globally each day1.  
Tuberculosis probably causes 6% of all deaths world wide.  One third of 
them are in Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan and 
Srilanka.  The average prevalence of all forms of tuberculosis in India is 
estimated to be 5.05 per thousand and the average annual incidence of 
smear positive cases is 84 per 1,00,000 annually1.  India has about 1.8 
million new cases of tuberculosis annually, accounting for one fifth of 
new cases in the world, a greater number than any other country1.  In 
2004 about 3,30,000 people in India died from tuberculosis. Tuberculosis 
is one of the deadliest diseases in the world killing nearly 2 million 
people every year.  More than 90% of all tuberculosis occurs in the 
developing countries. 
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According to the WHO, there where 4,50,000 deaths due to TB in 
children under 15 years of age in 1989.  75% of all childhood tuberculosis 
cases occur annually in 22 high burden countries mostly in sub-Saharan 
Africa.  In developing countries, TB is responsible for 10% or more of 
the childhood hospital admission and 10% or more of hospital death. 
Recently the global burden of tuberculosis in children and its impact on 
child health are being increasingly recognized, in part because of the 
reemergence of tuberculosis as a major public health problem in 
developing countries. 
Children less than 5 years old and infected with tuberculosis are at 
higher risk of developing disease probably due to immature cellular 
immunity.  Exposure to tuberculosis is determined by the degree and 
nature of contacts with source cases as well as duration of infectiousness 
of the source cases.  Factors such as family size, living space, population 
density, and the age of tuberculosis patients in a given setting determine 
the number of infections per infectious case.   
Children can present with tuberculosis at any age but majority of 
cases  present between 1 and 4 years.  Disease usually develops within 
one year of infection in younger individuals and the progression to 
disease is earlier and more disseminated.  Pulmonary tuberculosis is 
usually smear negative.  Pulmonary tuberculosis (PTB) to extra 
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pulmonary tuberculosis (EPTB) ratio is usually around 3:1.  In infants, 
the time span between infection and disease can be as little as 6 to 8 
weeks7. 
Untreated adults pass the disease on to 43 % of children under one 
year and to 16 % of children from 11 to 15 years old.  Only 5 to 10 % of 
adults with similar contact would contract the disease. Pulmonary 
tuberculosis is primarily an adult disease and it has been estimated that in 
0 - 19 years old population pulmonary tuberculosis is only 7 %. 
Childhood tuberculosis arises most often as a result of the 
inhalation of mycobacterium tuberculosis bacilli expectorated by sputum 
smear positive adult pulmonary tuberculosis patients through aerosol 
droplets. The infective aerosol droplets are 5-10 micrometer in diameter 
and contain 1-3 bacilli. If infection is successfully established, a primary 
focus form in the lung parenchyma, most often subpleural in location, and 
bacilli spread to regional lymphnodes and later via the lymph and blood 
to organs throughout the body.  Depending upon the age and integrity of 
the immune system and perhaps the virulence of the infecting organisms, 
a majority of infections are either contained, usually at the site of primary 
focus and regional lymphnodes or may spread to extra pulmonary sites 
where the disseminated bacilli might get lodged. 
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TYPES OF TUBERCULOSIS 
Pulmonary tuberculosis: 
Primary tuberculosis denotes the first time infection in a previously 
uninfected child. The basic lesion formed during the primary infection, 
the primary focus (Ghon’s focus), lymphangitis and lymphadenitis, are 
collectively called as primary complex of Rankey or pulmonary primary 
complex19. 
Progressive primary complex denotes the extension of the disease 
beyond the primary focus and the regional node by bronchogenic or 
hematogenous spread. The various forms of tuberculosis which develops 
following  bronchogenic spread are as  follows.  
a) Incomplete bronchial obstruction with ball valve mechanism 
leading to obstructive emphysema. 
b) Aspiration of caseous material into the lung may result in 
tuberculous bronchopneumonia and consolidation.  
c) Complete obstruction with absorption of air results in collapse of 
the lung distal to the obstruction or collapse consolidation. 
d) If these complications are not attended to, the sequelae is 
bronchiectasis 
Secondary tuberculosis denotes all active tuberculosis which can occur 
any time after the primary infection or disease, due to endogenous 
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reactivation or exogenous reinfection. Other terminologies used are 
reinfection tuberculosis, post-primary tuberculosis, chronic tuberculosis 
or adult type of tuberculosis. 
Hematogenous dissemination 
Tubercle bacilli are liberated intermittently and gradually into the 
blood stream and carried to other parts of the body during the formation 
of primary complex. This can happen without the development of clinical 
illness resulting in disseminated lesion. If caseous node erodes a nearby 
vein and liberates large number of organisms, seeding may be sudden, 
heavy and widespread resulting in miliary tuberculosis19. 
Cavity formation is the hallmark of secondary tuberculosis, usually 
seen in the apices of the lung. Since the incidence of adult tuberculosis is 
high in our community, cavitating tuberculosis is increasingly seen even 
in younger age group. In adolescents fibrous bands, calcified spots in the 
pulmonary parenchyma, hilar nodes, mediastinal nodes and pleura 
indicate healed lesions. 
Extrapulmonary tuberculosis 
Children with extrapulmonary tuberculosis (EPTB) present with 
constitutional symptoms such as fever, loss of appetite, weight loss, 
malaise and fatigue. These patients manifest symptoms and signs related 
to the organ system involved. Since hematogenous spread of tuberculosis 
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is common in children, extra pulmonary complications are considerably 
high when compared to adults.  
Tuberculous pleural effusion 
It is due to seeding of pleura with Mycobacterium tuberculosis. It occurs 
due to lymphatic spread, 3 to 6 months after the initial infection. TB 
pleural effusion usually presents as an acute illness with fever, pleuritic 
chest pain, nonproductive cough and dyspnoea. Many children may 
present as silent effusion without much constitutional symptoms. The 
effusion is usually unilateral due to unexplained reasons but can be 
bilateral too19. Tuberculous effusion is straw colored and exudative in 
nature (protein concentration more than 3 g/dl).  Empyema is a rare 
complication of untreated tuberculosis.  
Pericardial involvement by TB may present as acute pericarditis, 
chronic pericarditis. Pericardial involvement results from direct extension 
of infection from adjacent mediastinal lymph nodes or through lympho-
haematogenous route. 
Tuberculous adenitis 
Lymph node TB (LNTB) is the commonest form of EPTB. LNTB 
is considered to be the local manifestation of a systemic disease. Patients 
usually present with slowly enlarging lymph nodes and may otherwise be 
asymptomatic. Isolated cervical lymphadenopathy is most often seen in 
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about two-thirds of the patients who present with painless, matted, lymph 
nodes.  
Gastrointestinal Tuberculosis :  
 Abdominal Tuberculosis can affect any part of GIT right from 
oesophagus. Ileum and ileocaecal region are commonly involved. 
Gastrointestinal TB can be of ulcerative, hypertrophic, 
ulcerohypertrophic, diffuse colitis and sclerotic forms. Abdominal pain is 
the most common symptom. Diarrhoea, anorexia, weight loss and fever 
are also common. Other symptoms include a moving lump in the 
abdomen, nausea, vomiting, malena and constipation19. A doughy feel of 
the abdomen, mass in the right iliac fossa due to hyperplastic caecal TB, 
lymph node enlargement and rolled up omentum may be clinically 
elicited. It can also present as intestinal obstruction or peritonitis. 
Peritoneal Tuberculosis 
Tuberculous peritonitis may present as acute abdomen or as chronic 
TB peritonitis which is of 3 varieties19: 
a) Ascitic form 
b) Encysted or loculated form 
c) Fibrous form 
Other abdominal sites 
Hepatobiliary tract, pancreas and splenic TB 
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Bone and joint Tuberculosis 
Skeletal TB is a haematogenous infection. It commonly affects the 
spine and hip joint. Other sites include knee, foot, elbow joints and hand 
bones. Rarely affects the shoulder joint. 
Spinal TB is the most common form of skeletal TB. Constitutional 
symptoms generally occur before the symptoms related to the spine 
manifest. Lower thoracic and lumbar vertebrae are the most common 
sites of involvement followed by middle thoracic and cervical vertebrae. 
Usually, two contiguous vertebrae are involved but several vertebrae may 
be affected and skip lesions are also seen19. 
The infection begins in the cancellous area of the vertebral body, 
commonly in the epiphyseal location and less commonly in the central or 
anterior area of vertebral body. The infection spreads and destroys the 
epiphyseal cortex, the intervertebral disc and the adjacent vertebrae. It 
may spread to the neighbouring vertebrae19. The vertebral body becomes 
soft and gets compressed to produce either wedging or total collapse. The 
paravertebral abscess may compress the spinal cord or may track down to 
the mediastinum to enter around the trachea, oesophagus or into the 
pleural cavity. It may spread laterally around the sternomastoid muscle 
and form an abscess in the neck. Rarely, a thoracic cold abscess may 
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follow the intercostal nerve to appear anywhere along the course of nerve 
i.e. empyema necessitans. 
Neurological Tuberculosis 
Tuberculous meningitis 
TB meningitis (TBM) accounts for 70%-80% of cases of neurological 
TB. 
The disease usually evolves gradually over two to six weeks19. 
a) The prodromal phase: It lasts for two to three weeks and is 
characterized by a history of vague ill-health, apathy, irritability, 
anorexia and behavioural changes. 
b) Meningitic phase: with the onset of meningitis, headache and 
vomiting become evident and fever develops. Focal neurological 
deficits and features of raised intracranial tension may precede 
signs of meningeal irritation. Focal or generalized seizures, cranial 
nerve palsies, complete or partial loss of vision are the major 
complications of TBM. 
c) Deep coma phase: If untreated the terminal illness is characterized 
by deep coma and decerebrate or decorticate posturing. Without 
treatment, death usually occurs in five to eight weeks. Atypical 
presentations include acute meningitic syndrome simulating 
pyogenic meningitis, progressive dementia, status epilepticus, 
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psychosis, stroke syndrome, trigeminal neuralgia, infantile spasm 
and movement disorders. 
Tuberculomas 
Intracranial tuberculomas in patients under the age of 20 are 
usually infratentorial, but supratentorial lesions predominate in adults. 
Solitary tuberculomas are more frequent than multiple lesions. 
Tuberculoma is diagnosed by contrast enhanced CT scan as a ring 
enhancing lesion. 
Ocular Tuberculosis 
In ocular TB, the choroid is the most commonly affected structure. 
Primary ocular TB is extremely rare and it is usually secondary. 
Disseminated / Miliary Tuberculosis 
DTB refers to the involvement of two or more non-contiguous sites 
by TB disease. Dissemination can occur during primary infection or after 
reactivation of a latent focus/ reinfection. 
Genito-urinary Tuberculosis 
Genito-urinary tuberculosis is rare in the childhood as it occurs 5-6 
years after the establishment of primary complex. Genito-urinary TB  
may present as dysuria, painless haematuria, flank pain, renal mass, 
sterile pyuria and recurrent urinary tract infection. 
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Perinatal tuberculosis: 
Tuberculosis can be acquired in the perinatal period.  Symptoms 
and signs are non specific.  Diagnosis is by clinical suspicion, culture of 
gastric washings, liver biopsy specimens, lymphnode biopsy specimen, 
spinal fluid, ear discharge, endotracheal aspirate or bone marrow and 
perhaps x-ray. There can be two types of perinatal tuberculosis. 
a) Postnatal tuberculosis: 
Infections occur after birth via airborne inoculation from 
close contacts (family members or nursery personnel). 
Clinical manifestation 
The clinical presentation of tuberculosis is non-specific but is 
usually marked by multiple organ involvement.  The neonate may 
look acutely or chronically ill.  Fever, lethargy, respiratory distress, 
hepatosplenomegaly and failure to thrive may indicate tuberculosis 
in neonate with a history of exposure. About 50% of children borne 
to mothers with active pulmonary tuberculosis develop the disease 
during the first year of life if chemoprophylaxis and BCG vaccine 
are not given. 
b) congenital tuberculosis: 
Congenital tuberculosis is a very rare condition.  Only 300 cases 
were reported in the literature till 1989.  It is because placenta 
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forms a protective barrier against the invasion of the fetus by the 
tuberculosis bacilli.  
Mode of infection: 
Three possible modes of infection of the fetus have been 
proposed.  Hematogenous infection via the umbilical vein         
transplacentally to the fetal liver, fetal aspiration of infected 
amniotic fluid and fetal ingestion of infected amniotic fluid19. 
Clinical manifestation: 
The affected infant is frequently born premature, but signs of 
disease usually do not appear for several days or weeks.  The most 
common presentation is with respiratory distress, lethargy, poor 
feeding, fever, irritability, abdominal distension and failure to 
thrive.  Hepatosplenomegaly and lymphadenopathy are common.   
Investigations: 
Congenital tuberculosis is particularly difficult to diagnose 
and high index of suspicion is important when mothers have active 
tuberculosis and belong to low socioeconomic status.  The mothers 
are often apparently healthy.  Onset of progressive neonatal icterus 
with hepatosplenomegaly after two weeks of age and complication 
of severe pneumonitis with failure to thrive should arouse suspicion.   
1) Mantoux test is frequently negative 
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2) Chest radiograph shows the presence of scattered infiltrates, 
bronchopneumonia, consolidation and computed tomography of 
abdomen may show periportal hypodensity.   
3) Positive smear and / or culture results can often be obtained from 
gastric washings, liver biopsy, lymphnode biopsy, spinal fluid, ear 
discharge and endotracheal aspirate or bone marrow 
4) Newer modalities like polymerase chain reaction (PCR) are highly 
beneficial in the diagnosis of congenital tuberculosis 
5) Recently phage typing has been used to establish the identity of 
Mycobacteria isolated from mother and the infant. 
Diagnostic criteria: 
Diagnostic criteria for the diagnosis of congenital tuberculosis were 
laid down by Beitzki in 1935 and subsequently were revised by cantwell 
in 1994. 
Diagnostic criteria for congenital tuberculosis – Revised criteria by 
cantwell 
Proven tuberculosis lesions in the infant plus one of the following5 
i) Lesion occurring in the first week of life 
ii) A primary hepatic complex, 
iii) Maternal genital tract or placental tuberculosis  
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iv) Exclusion of postnatal transmission by thorough investigation of 
contacts. 
Prognosis: 
The prognosis was poor in the pre-chemotherapy era, the reported 
survival rate was very low (around 50%), but since the advent of  
chemotherapy, the chance of successful treatment have improved the 
overall survival.  Delay in the diagnosis contributes to the increased 
mortality6. 
Prevention: 
Prevention should be possible through early detection of disease 
during pregnancy and institution of appropriate therapy.  Routine 
neonatal BCG vaccination is indicated in developing countries. 
HIV INFECTION IN CHILDREN: 
EPIDEMIOLOGY AND TREND OF HIV IN INDIA: 
Nearly 25 million people have died world over due to HIV since 
1891. It is estimated that currently 38.6 million people live with HIV 
infection world over, of which 2.3 million i.e. 5.9% are children < 15 
years of age. Though children represented only 6% of all these as of 
December 2005, they accounted for 18% of the 3.1 million AIDS deaths 
in 2005; and this is because only 40,000 or 4% of the one million people 
now on antiretroviral treatment are children. This means that one in every 
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six AIDS deaths each year is a child, yet children represent less than one 
of every twenty-five persons getting treatment in developing countries 
today. 
In 2005, more than 540,000 children were born with HIV infection 
transmitted from their infected mothers, 90% of them in sub-Saharan 
Africa and remaining in Asia, mainly India. 
The estimated total number of HIV infection in India was 3.5 
million in the year 1998, 3.5 million in 1998, 3.71 million in 1999, 3.86 
million in 2000, 3.97 million in 2001, 4.58 million in 2002, 5.1 million in 
2003 and 5.134 million in 2004. The estimated number of children living 
with  HIV / AIDS in India is 0.17 million (UNAIDS 2004 report) to 0.24 
million (NACO estimates based on % of AIDS cases), which means that 
they form less than 3.5 – 5% of people living with HIV in the country9. 
Unlike in adults where more than 90% of the time HIV infection 
occurs through sexual route, in the developing countries 95% of cases in 
children occur due to vertical transmission from their infected parents. 
The risk of mother to child transmission of HIV infection varies from 
country to country and also within a country depending on the facilities 
available. It is 15-30% in non-breast feeding populations, whereas it is  
30 – 45% in countries where breast feeding is a norm. This is because 
breast feeding has an additional 5- 20% risk of postpartum transmission10. 
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In June 2001, the member countries pledged at the United Nations 
General Assembly Special Session on HIV / AIDS (UNGASS) to reduce 
the mother to children transmission of HIV by >20% by 2005 and by 
>50% by 2010. This was further reaffirmed at the United Nations summit 
in September 2005. However by 2005, only 9% of the pregnant women 
living with HIV infections actually received ARV prophylaxis for 
PMTCT world over. 
TRANSMISSION AND PATHOGENESIS OF PAEDIATRIC HIV 
DISEASE 
Transmission of HIV: 
HIV virus is present virtually in all the body fluids of HIV infected 
individuals. Blood and genital fluids (seminal, vaginal and cervical 
secretions) contain high concentration of free HIV virus and HIV infected 
cells. Although saliva contains HIV (in very low titers < 1 infectious 
particles/ml), it is not likely a vehicle of transmission as it contains 
nonspecific inhibitory substances like fibroblasts and glycoproteins, 
which could prevent cell-to-cell transfer of virus. Urine, sweat, amniotic 
fluid, synovial fluid, faeces and tears have been reported to yield zero or a 
few virus particles. Hence, these vehicles also do not appear to be 
important in transmission12. The efficiency of HIV transmission is 
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determined by the amount of virus in the body fluid and the extent of 
contact. 
Route of Transmission: 
The usual routes of transmission in children are vertical transmission 
from infected mother to child; blood and blood product transfusions18. 
1. Vertical transmission from mother to child: 
This is the primary route of infection in pediatric age group 
accounting for more than 90% of HIV-1 infected infants and children 
globally. Vertical transmission of HIV can occur during pregnancy (in 
utero) labour and delivery (intrapartum) or through breast-feeding 
(postpartum). 
Rate of Transmission: 
Without any intervention overall vertical transmission rates range 
from 16-20% in developed countries and 25-45% in developing 
countries15. This difference is largely attributed to prevalence of 
prematurity and under-nutrition among mothers in developing countries. 
Timing and mechanism of transmission: 
Virologic analysis of aborted fetuses indicates that HIV can be 
transmitted to the fetus as early as the first and second – trimester of 
pregnancy17. The highest percentage of transmission occur during labor 
and delivery, either through trans-placental transfer of virus (micro-
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transfusion) during late pregnancy or at the time of labor and delivery due 
to exposure of the skin and mucous membrane to infected blood and 
cervico-vaginal secretions in birth canal. Infections through breast-
feeding occur due to exposure of mucous membrane to free and cell 
associated virus in the breast milk. Some of the facts about transmission 
through breast-feeding are18: 
1. Transmission can take place at any point during breast feeding. 
2. About 70% transmission occurs during first 4-6 months. 
3. The longer the breast-feeding is continued the higher is the risk. 
4. Mixed feeding increases the risk of transmission (food antigen and 
pathogens traumatize the intestinal mucosa causing a breach in the 
integrity of epithelial layer thereby permitting the virus to enter the 
damaged mucosa). 
Risk factors for vertical transmission: 
Several maternal, viral and fetal factors influence the rate of 
vertical transmission. Prematurity, advanced maternal HIV disease, 
exposure to maternal blood, firstborn twin, rupture of membrane > 4 
hour, breastfeeding and higher maternal viral load are associated with 
higher risks for HIV transmission. However, the relative contribution of 
each individual factor is yet to be determined. The reported transmission 
rate among women with plasma HIV RNA < 1,000 copies/mL is almost 
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0%16. However, transmission has been reported among women with all 
levels of maternal HIV RNA (including undetectable levels). Although 
caesarean section has shown to decrease the transmission rate, the 
additional rate, with the advent of availability of HAART, the additional 
benefit is probably negligible if the mother’s viral load is <500 viral 
copies/ml. 
2. Blood borne infections: 
This is the most efficient route of transmission of HIV. HIV infected 
blood, blood products, transplanted organs or tissues and HIV 
contaminated improperly sterilized needles and syringes can transmit 
HIV16. Transmission through transfusion of infected blood or blood 
products account for 3-6% of pediatric infections. In recent years, 
mandatory screening of blood or blood products for HIV before 
transfusion has significantly reduced the risk of this mode of 
transmission; although a small number of cases still continue to occur in 
many developing countries. 
Natural History and Pathogenesis of HIV-1 Disease in Children: 
 Three distinct patterns of pediatric HIV disease were described 
before the era of HAART viz. rapid progressors, slow progressors and 
long term survivors. Approximately 15-25% of HIV infected newborns 
are rapid progressors with appearance of symptoms during the first few 
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months of life and have detectable virus in the plasma in the first 48 hrs 
of life and a median survival of 6-9 months17. They are considered 
infected in utero. As the infections occur during the period of rapid 
expansion of CD4 cells in the fetus, the majority of the body’s 
immunocompetent cells would be infected before their migration to the 
marrow, spleen and thymus. This results in efficient systemic delivery of 
HIV and establishment of infection before normal development of 
immune system causing more severe immune impairment. The viral load 
rapidly increases and peaks by 2-3 months of age and subsequently 
decline slowly. In contrast to the viral load in adults, the viral load in 
infants stays high for atleast the first 2 years of life.  
Early HIV-1 replication in children has no apparent signs and 
symptoms. The incubation period of HIV-1 infection in children is 
generally shorter after perinatal infection compared to adult HIV-1 
infection. B cell activation occurs in most children early in the infection15. 
Hypergammaglobulinemia with production of nonfunctional 
antibodies (polyclonal) is more common among HIV-1 infected children 
than adults, commonly noted as early as 3 to 6 months of age18. This 
response may reflect both dysregulation of T cell suppression and B cell 
antibody synthesis and active CD4 enhancement of B-Lymphocyte 
humoral response. There is a reduced ability to respond to new antigens 
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with appropriate immunoglobulin production. This results in greater 
frequency and severity of invasive bacterial infections in pediatric HIV-1 
infection due to lack of prior antigen exposure. Depletion of CD4 
lymphocytes may not be as readily apparent in HIV-1 infected infants and 
young children as they have relative lymphocytosis, including CD4 
lymphocytes. However, the CD4 cell percentage is relatively similar at all 
ages in infants and children and can frequently be used to detect CD4 
lymphocytes abnormalities caused by HIV-1 infection. In HIV-1 infected 
children, opportunistic infections are frequently more severe or rapidly 
progressing because these infections often represent primary infection as 
compared to reactivation infection commonly seen in adults. 
Central nervous system (CNS) involvement is more common in 
pediatric patients than in adults. Macrophages, microglia and astrocytes 
play an important role in HIV neuropathogenesis. Infected monocyte 
(utilizing the cytokine cell receptor CCR5) may act as latent but inducible 
reservoirs of virus, and may carry virus to organs, particularly the brain in 
which they become resident. Although the specific mechanisms for 
encephalopathy in children are not yet clear, the developing brain with 
immature blood brain barrier and delayed myelinization in young infant is 
more vulnerable to invasion by HIV. 
 
22 
 
Clinical Manifestations: 
HIV infection often presents with diarrhea, lymphadenopathy, 
hepatomegaly, splenomegaly, parotid swelling, Lymphoid Interstitial 
Pneumonitis. 
Skin Manifestations: 
The common skin infections seen in HIV infected children are  
seborrheic, atopic and generalized dermatitis, lesion due to nutritional 
deficiency, eczema, psoriasis, drug eruptions and alopecia. 
Manifestations due to hematological abnormalities: 
Anaemia presenting as pallor and thrombocytopenia, which can 
present with petechiae and ecchymoses is likely to be diagnosed as 
“immune thrombocytopenia”2 
Cardiac Manifestations: 
Cardiomegaly, congestive cardiac failure, non-bacterial thrombotic 
endocarditis, cardiomyopathy, pericardial effusion, cardiac tamponade, 
conduction disturbances and sudden death are known to occur2. 
Cardiomyopathy frequently accompanies HIV encephalopathy. 
Gastrointestinal Manifestations: 
Diarrhoea, dysphagia, retro-sternal pain, difficulty in drinking 
fluids and excessive salivation are related opportunistic infections. 
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Affection of Physical Growth: 
HIV infection adversely affects the growth of infected children. 
Neurological Manifestations: 
HIV encephalopathy can present with developmental delay or with 
regression of milestones. 
Malignancy: 
     Non-Hodgkin’s lymphoma, leiomyomas, leukemias and 
leiomyosarcoma. 
Nephropathy: 
Proteinuria, hematuria, hypertension, renal tubular acidosis, acute 
renal failure and progression to end-stage renal disease. 
Ocular Manifestations: 
CMV retinitis, anterior uveitis, retinal detachment and vitreous 
hemorrhage are some of the ocular lesions observed in HIV infected 
children. 
Opportunistic Infections: 
Opportunistic infections constitute one of the commonest features 
of symptomatic HIV infection in children. In any immunodeficient 
disorder, the type of organisms predominantly encountered depends upon 
the type of immune defect2. HIV infection directly or indirectly affects 
the cellular as well as the humoral arms of the immune system. In 
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addition, associated factors such as malnutrition, use of 
immunosuppressive drugs and presence of indwelling catheters add to the 
defective immunity. Hence, these children suffer from viral, bacterial, 
fungal, protozoan as well as mycobacterial opportunistic infections. 
Presumptive diagnosis of severe HIV disease in infants <18 months2: 
Clinical criteria for presumptive diagnosis of severe HIV disease in 
infants and children less than 18months of age requiring ART in 
situations where virological testing is not available. 
A presumptive diagnosis of severe HIV disease should be made if: 
¾ The infant is confirmed HIV antibody positive;  And 
¾ Diagnosis of any AIDS-indicator condition(s) can be made; Or 
¾ The infant is symptomatic with two or more of the following: 
• Oral thrush; 
• Severe pneumonia; 
• Severe sepsis. 
Other factors that support the diagnosis of severe HIV seropositive 
infant include: 
Recent HIV- related maternal death; or advanced HIV disease in the 
mother;  
CD4 < 20%. 
Confirmation of the diagnosis of HIV infection should be sought as soon 
as possible. 
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Laboratory Diagnosis of HIV Infection2 
 
Anti-HIV antibody 
tests 
 
 
Antigen 
detection 
 
 
Virus isolation / 
detection of viral 
nucleic acids 
 
 
Screening tests       
(Micro well ELISA tests, 
Rapid tests) 
 
P24 antigen 
assay 
Viral culture 
Supplemental tests 
(Western blot, line 
immunoassay, 
recombinant 
immunoblotting assay) 
PCR tests          
(DNA / RNA) 
 
 
 
Antibody Tests 
For infants born to HIV positive mothers, the passively transmitted 
HIV antibodies persist in circulation till 18 months. Though antibody test 
at 12 months can be used to exclude the infection (if negative), it may be 
necessary to repeat the test at 18 months (especially if the test at 12 
months is positive) to exclude maternally transmitted antibodies. The 
antibodies start waning off from 12 months of age in infants. In breast 
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feeding mothers, the test needs to be repeated 3 months after cessation of 
the breast feeding for excluding HIV infection in the child. 
ELISA (Enzyme linked immunosorbent assay) 
ELISA is the most common test used for detection of HIV 
antibodies (anti-HIV1 and anti-HIV2) and is almost 100% sensitive and 
specific. Various techniques include indirect ELISA, direct ELISA, 
competitive ELISA, antigen sandwich ELISA, and antigen-antibody 
capture assay. 
Rapid Tests 
The rapid tests yield results in up-to 3 to 30 minutes (as compared 
to ELISA which takes 3 hours), and have high sensitivity (100%) and 
specificity (99%). These include dot blot assays, particle agglutination 
(gelatin, RBC, latex, microbeads), HIV spot & Coomb’s tests and 
fluorometric microparticle technology. 
Western Blot Analysis 
Western blot analysis is done by electrophoresis of plasma on pre-
impregnated strip containing various antigens of HIV and is considered 
positive if at least 2 out of 3 bands (p24, gp41, gp120/160) are positive. 
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HIV p24 Antigen: 
HIV p24 antigen can be detected and quantified using EIA, with 
high sensitivity (79%) and excellent specificity (99%) and correlates well 
with disease progression. 
HIV Viral Culture: 
HIV culture is a highly sensitive and specific test but requires high 
degree of expertise, high cost and intensive laboratory facilities. It helps 
in the early diagnosis of infection in newborns and is useful in infected 
patients who have not yet developed antibodies (window period, 
hypogammaglobulinemia, and late symptomatic phase with severe 
immunosuppression). 
HIV PCR: 
Two types of PCR are available; HIV-DNA PCR from provirus in 
infected T cells and HIV-RNA PCR from free virions in plasma.  
Quantitative PCR can detect as low as 10 copies/ml of virus in plasma. 
HIV PCR helps in early diagnosis in infected newborns and is useful in 
infected patients who have not yet developed antibodies.  
HIV-DNA PCR 
HIV-DNA PCR is a qualitative test that detects the proviral DNA 
integrated with the host cell, performed using the reverse transcriptase 
PCR. 
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HIV-RNA PCR 
HIV-RNA PCR is a quantitative test using reverse transcriptase or 
nucleic acid sequence based amplification and branched chain DNA 
techniques. 
CD4 Counts2: 
Absolute CD4 counts and CD4 percentage are determined for deciding 
the level of immunosuppression, point of initiating antiretroviral therapy 
and monitoring the response to the therapy. CD4 cutoffs predict risk of 
clinical disease progression & mortality. CD4 percentage & CD4 counts 
are higher in infants compared to that of adults & fall to adult values by 
age 5 years. Also, the counts vary due to diurnal change, intercurrent 
illnesses, steroid treatment, splenectomy, etc. Hence repeated 
measurements are more informative than one single value. The absolute 
CD4 counts change with age of the child. CD4 percentage does not vary 
as much with age and hence this is used in determination of the level of 
immunosuppression. The decision to start antiretroviral therapy is based 
on clinical indicators supplemented with the CD4 counts. It also helps to 
monitor disease progression. When the CD4 count is more severely 
affected than the clinical stage, one should consider CD4 cutoff for 
initiation of antiretroviral therapy. 
 
29 
 
Tuberculosis in HIV: 
Approximately 10 million people are estimated to be co infected 
with mycobacterium tuberculosis and HIV, and over 90% of these dually 
infected individuals reside in developing nations1. Worldwide, 
tuberculosis is the most common cause of death among patients with 
AIDS, killing one of every three patients8. 
People with latent tuberculosis are increasingly becoming florid 
with HIV, and many more are developing active tuberculosis because 
HIV is weakening their immune system.  There are several important 
association between epidemics of  HIV and tuberculosis 
1) Tuberculosis is harder to diagnose in HIV positive people 
2) Progresses faster in HIV infected people 
3) In HIV positive people it is more likely to be fatal if or 
left untreated 
4) Occurs earlier in the course of HIV infections than other 
opportunistic infections. 
5) Is the only major AIDS related opportunistic infection 
that poses a risk of HIV negative people. 
There is increased risk of tuberculosis among HIV infected 
children and infact coinfection with HIV occurs in upto 48% of the 
children with culture proven tuberculosis.  Extra pulmonary and miliary 
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tuberculosis are more among younger children6.  Children usually get 
tuberculosis from an infected close adult and disease in the children is 
usually a primary infection rather than reactivation disease.  An 
asymptomatic child with a positive mantoux suggests a latent infection 
and all latent  infections should be treated to prevent the disease.  Drug 
resistant tuberculosis is on the rise and thus contact to drug resistant 
tuberculosis should be treated with assumption that any newly diagnosed  
infection is similarly drug resistant.  If there is any patient with 
tuberculosis then all exposed family members should be screened for 
tuberculosis. 
Clinical features 
Pulmonary tuberculosis may present with  nonspecific symptoms 
such as fever, weightloss, failure to thrive and cough.  Features of 
presentation in HIV infected children are similar to those among non HIV 
infections.   
Extrapulmonary Tuberculosis 
Common sites involved are lymph nodes, disseminated TB, CNS 
TB, bone TB and TB of the serosal surfaces. With disease progression of 
HIV, atypical features of TB are more common10. 
Suspect TB if the child has: 
a) Contact with adult who has pulmonary TB 
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b) Fever for more than 2 weeks 
c) Chronic cough 
d) Ongoing weight loss or poor weight gain 
e) Pneumonia not responding to antibiotics 
f) Recent glandular enlargement. 
Mantoux test (tuberculin test) 
It can be done from three months onwards. Induration more than 
5mm is considered positive in HIV infected children. However negative 
result may be seen in over 50% of children with tuberculosis. Thus a 
negative result does not exclude TB. 
Gastric lavage/ sputum examination: 
Though acid fast stained sputum smears are positive in 50% to 
70% of adults with pulmonary TB, children with TB disease rarely 
produce sputum voluntarily and have a low bacterial load. Three 
consecutive morning gastric aspirates have a better yield than a single 
sample. Better diagnostic yield is seen on culture. 
Other fluids and tissues for culture: 
Bronchoalveolar lavage, lung biopsy, lymphnode biopsy, serosal 
fluids and CSF may be used for diagnosis. Specimens should be cultured 
for 2 to 6 weeks by radiometric culture methods (Bactec) or culture on L-
J medium for 8 weeks12. Antimycobacterial drug sensitivity should be 
32 
 
done on initial positive culture, if treatment fails or relapse occurs. If no 
organism is isolated from the specimen of the child, drug sensitivity test 
can be done on the isolate from the source case. 
Chest X-ray: 
May show 
a) Localized pulmonary infiltrates with hilar adenopathy 
b) Middle lobe collapse 
c) Pleural effusion 
d) In older children cavitatory tuberculosis. 
Extrapulmonary cause: 
Culture of affected body fluid or tissue obtained by fine needle aspiration 
or biopsy. 
PCR assays: 
Not useful as primary diagnostic tool because a negative PCR does 
not rule out TB and a positive result does not absolutely confirm 
M.tuberculosis infection. Also false positive rates are high with 
sensitivity ranging from 45-83%. Serological tests for TB are not very 
specific. 
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1. Frequency of HIV infection amongst children with disseminated 
tuberculosis and tuberculous meningitis in Aligarh (North India) 
– a low HIV prevalence area. 
 Done in Department of Paediatrics, Jawaharlal Nehru Medical 
College, AMU, Aligarh, India. 
ABSTRACT 
Objective: 
To determine the frequency of HIV in children with disseminated 
tuberculosis and tuberculous meningitis in a low HIV prevalence area, 
and to study clinical profile of those found HIV positive. 
Study design: 
Cross-sectional, descriptive study. 
Place and duration of study: 
Jawaharlal Nehru Medical College, Aligarh Muslim University, 
Aligarh, India from February 2005 to January 2008. 
Methodology 
The study was conducted on 215 children under 14 years of age 
with either disseminated tuberculosis or tuberculous meningitis. HIV 
infection was diagnosed in accordance with WHO strategy II. In children 
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younger than 18 months, the strategy (to cut down costs) was to screen 
first by HIV antibody testing and subject only positive cases to 
virological tests. Parents of HIV positive children were also tested for 
HIV and counselled. The clinical profile of HIV positive patient was 
noted. 
Results 
The frequency of HIV in all cases of TB was 5.12%, while that in 
cases of disseminated tuberculosis was much higher (22%). No case with 
isolated tuberculous meningitis was HIV positive. The majority (45.45%) 
of patients with HIV were between 1-5 years of age. The mode of 
infection in 7 (63.63%) cases was parent to child transmission. Loss of 
weight, prolonged fever, pallor, hepato-splenomegaly and oral candidiasis 
were the commonest clinical manifestations among HIV positive patients. 
Conclusion: 
Clinically directed selective HIV screening in cases of disseminated 
tuberculosis can pickup undiagnosed cases of the same in areas with low 
prevalence of HIV infection. 
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2. HIV-1 co-infection in children hospitalized with tuberculosis in 
South Africa. 
Done in Department of Paediatrics, University of the Witwatersrand, 
Johannesburg, South Africa.  shabirm@mail.sailmr.wits.ac.za 
ABSTRACT 
Setting: 
Hospitals associated with the Department of Paediatrics at the 
University of the Witwatersrand, Johannesburg, South Africa. 
Objectives: 
To define the prevalence of human immunodeficiency virus 
coinfection and differences in clinical presentation between HIV-infected 
and non-infected hospitalized children with tuberculosis. 
Design: 
Children were prospectively enrolled between August 1996 and 
January 1997. 
Results: 
Out of 161 children enrolled, 42% were HIV-infected, including 
67/137 with pulmonary tuberculosis and 1/24 with extra-pulmonary 
disease. Positive microscopy or bacteriology did not differ by HIV status 
for children with either PTB or EPTB. Although age did not differ 
between HIV infected and non-infected children with PTB, non HIV 
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infected children with EPTB were significantly older than those with PTB 
(median age 32 months vs 14.5 months, p = 0.004). chronic weight loss, 
malnutrition and the absence of BCG scarring were more common in 
HIV infected children with PTB. HIV-infected children were also more 
likely to show cavitation (p = 0.001) and miliary TB (p= 0.01) on chest 
X-ray. Reactivity to tuberculin (> or = 5mm and > or = 10 mm in HIV 
infected and non-infected children, respectively) was significantly lower 
in HIV infected children, as were CD4+ lymphocyte levels. The mortality 
rate during the study was 13.4% in HIV infected children compared with 
1.5% in non HIV infected children (p = 0.03). 
Conclusion: 
There is a high prevalence of HIV coinfection in children with TB. 
Progressive PTB and death are more common in HIV infected children. 
Tuberculin skin testing is of limited use in screening for TB in HIV 
infected children even when using a cut-point of > or = 5 mm. 
3. Seroprevalence of HIV infection among pediatric tuberculosis  
patients  in Agra,India: A hospital- based study - Summary  
In this study which was carried over a period of 2 years, from 2003 to 
2004, 270 paediatric patients with active Tuberculosis disease attending 
the OPD of S.N. Medical College, Agra were screened for Human 
Immunodeficiency Virus 1 and 2 antibodies. Of these, 23 were found to 
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be HIV-positive. Seroprevalence of HIV infection among paediatric TB 
patients in Agra is 8.51% (23/270). The HIV infection was found to be 
significantly higher, i.e. 82.61% in male children than in female children, 
i.e. 17.39%. Among the age groups, which were divided into 1, 2–5, 6–10 
and 11–15 years, maximum cases of HIV-positivity, i.e. 65.22% was 
observed in the age group, 2–5 years of age. Among the HIV-positive 
children with TB, 86.75% were of pulmonary and 13.04% were of extra-
pulmonary type. Among the vaccinated children, 65.22% were found to 
be HIV positive, while 34.78% of the HIV-positive children were not 
BCG vaccinated. 
HIV positive children are more likely to suffer from prolonged 
fever, weight loss, failure to thrive, developmental delay, stunted growth, 
cough, anorexia, lethargy, lower respiratory tract infections  and 
hepatosplenomegaly while HIV negative are more likely to suffer from 
fever, diarrhoea, lymphadenitis, pallor and LRTI. 82.60% (19/23) of these 
TB patients had a history of positive contact with HIV, i.e. one of the 
parents was HIV-infected. The mode of transmission of HIV infection 
among paediatric TB patients was perinatal as revealed during the 
counselling sessions (pre-test and post-test) of both the parents. 
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4. Jm Cohen et al studied UK based retrospective study from 1991-
2006 about TB and HIV co-infection. They studied 328 children 
(<16 yrs of Age) with HIV. Retrospectively they found that 18 
were co-infected with TB. Among the 18,10 were known HIV at 
the time of presentation. They concluded that screening of HIV in 
TB is the must. 
 
5. Madhi SA et al studied the HIV Co-infection in children with 
tuberculosis at the Dept. of Paediatrics, University of 
Witwatersrand Johannesburg, South Africa. They prospectively 
enrolled 161 children (<15years) with tuberculosis between August 
1996 to January 1997 out of that 42% of children were found to 
have HIV infection. So they concluded that high prevelance of HIV     
coinfection is seen with Tuberculosis 
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1. India has a high prevalence of HIV. However the prevalence of 
HIV in children who are newly diagnosed as TB is not known. 
2. To the best of our knowledge there are no such studies in 
Tamilnadu. 
3. TB statistics in our Institute of Child Health. 
                                        ICH & HC Statistics 
Year Total TB Cases Registered in   
TB Clinic 
2003 679 
2004 697 
2005 791 
2006 650 
2007 458 
 
 In spite of large number of patients treated at ICH every year, 
there is no    study about HIV screening in Tuberculosis infected children. 
4. The diagnosis of HIV in a TB patient has got varied consequences 
over the outcome as well as the treatment schedule for the disease. 
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5. The other part of my study deals with possible relation between the 
level of immunosuppression in HIV and the type of tuberculosis in 
that child. 
6. If there is a positive correlation, then proper guidelines regarding 
the same could be recommended. 
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AIM OF THE STUDY 
 
To document the prevalence of HIV infection among children with 
tuberculosis and correlation of CD4 cell count level with types of 
tuberculosis. 
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MATERIALS AND METHODS 
 
 STUDY DESIGN : 
           Descriptive study 
 PLACE:  
           Institute of Child health and hospital for Children, Egmore, 
Chennai. 
PERIOD OF STUDY:  
           2 years (OCT 2008 to OCT 2010) 
 STUDY POPULATION:  
          Children    0 to 12 years. 
INCLUSION CRITERIA 
Children aged below 12 years who are registered in TB Clinic at ICH.  
Children with parents who gave consent for the study. 
EXCLUSION CRITERIA 
Children with parents who did not give consent for the study. 
Children who are known to be  HIV positive already. 
METHODOLOGY 
  All children who are diagnosed as Tuberculosis using the modified 
Kenneth Jones criteria are included in this study after getting the consent 
of their parents.  
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Modified Kenneth-Jones criteria for the diagnosis of TB in children23.  
Score +3 Score +2 Score +1 Score -1 
Recovery of AFB 
from sputum, 
gastric aspirate, 
laryngeal swab, 
etc. 
X-ray chest 
suggestive of    
para-hilar 
lymphadenopathy 
with or without 
parenchymal 
lesions 
 
 
 
Non-specific 
chest X-ray 
changes 
BCG vaccination 
in the last 2 years
 
 
 
 
 
 
 
 
 
Tuberculous 
granuloma, 
granulomatous 
lesions in lymph 
node biopsy or 
choroid tubercles 
on fundoscopy 
Suggestive 
physical findings: 
pleurisy, skin 
lesion, 
osteomyelitis, 
Pott’s spine etc. 
Compatible 
physical findings: 
erythema 
nodosum, 
phlyctenular 
conjunctivitis, 
meningitis, 
cervical 
lymphadenitis, 
arthritis, 
hemoptysis, etc. 
 
Positive Mantoux 
test (MT) 
induration 
exceeding 10 mm 
Doubtful MT (5-
9mm) 
History of contact
With a patient 
suffering from 
TB 
 
 Recent MT 
conversion from 
negative to 
positive 
Non-specific 
granuloma 
 
 Contact with 
sputum smear-
positive patient 
Age below 2 
years 
 
  Non-response to 
therapy 
 
  3rd degree 
protein- energy 
malnutrition 
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According to this scoring system, 7 or more points indicate 
unquestionable TB; 5-6 points indicate probable TB, therapy may be 
justified; 3-4 points indicate that further investigations are needed. 
Types of Tuberculosis 
1. Pulmonary Tuberculosis 
2. Lymph node Tuberculosis 
3. Abdominal Tuberculosis 
4. Central Nervous System Tuberculosis (Tuberculoma / TBM) 
5. Spine Tuberculosis 
        Those children for whom the  parents have consented are subjected 
to tests like ELISA or PCR as per their age for the diagnosis of HIV . The 
WHO/NACO/UNAIDS strategies for diagnosis of HIV infection is 
followed.   In our study, strategy 2 and 3 are used for the diagnosis of 
HIV. 
 
STRATEGY 
 
 
STRATEGY 1 
Serum is subjected to ELISA/simple and rapid 
antibody test once. If negative the serum is considered 
as free of infection 
 
 
STRATEGY  2 
(symptomatic 
individuals) 
Sample is considerd negative if the first report is 
negative. If positive, is subjected to second ELISA 
antibody test and reported positive if the second test is 
positive. 
 
STRATEGY 3 
( Asymptomatic 
individuals) 
Additional to strategy 2 this includes a third ELISA 
confirmation before reporting as HIV positive. 
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    Those children who are HIV positive are subjected to further test. 
CD4 count is done for all children who turned out to be HIV positive at 
the ART centre and results are collected, extrapolated  and analysed. The 
CD4 grading is done according to the WHO revised classification of 
immunosuppression in children. 
Grading of immune status based on WHO Revised classification of 
immunosuppression in children2. 
Grade of 
Immunosuppression 
 
 
 
 
CD4 
values 
(%) <11 
months 
CD4 
values 
(%) 12-35 
months 
CD4 
values 
(%) 36-
59 
months 
CD4 
values (%) 
<5 yrs 
(cell/ 
mm3) 
Not significant >35 >30 >25 >500 
Mild 30-35 25-30 20-25 350-499 
Advanced 25-30 20-25 15-20 200-349 
Severe <25 <20 <15 <200 or 
<15% 
 
ANALYSIS 
    The results are extrapolated and analysed for HIV positivity rate 
among the Tuberculosis children and a correlation between CD4 count 
and type of TB was looked for. Data analysis was done with use of SPSS, 
version 10.Descriptive statistics were used to calculate the frequency, 
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mean, median and standard deviation. To examine the linear trend of 
proportions, trend chi-square was used and to findout the test of 
association chi-square was computed. 
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ANALYSIS OF OBSERVATION 
 
PREVALENCE: 
                
AGEWISE DISTRIBUTION OF TUBERCULOSIS 
Age Frequency Percent 
12-35   months  
 
7 9.7 
36-59   months  21 29.2 
≥ 60  months 44 61.1 
Total 
 
72 100 
 
AGEWISE FREQUENCY OF TUBERCULOSIS 
AGE
44
7
21
12 - 35 Months
36 - 59 Months
≥ 60 Months
 
TOTAL  TB INFECTED CHILDREN 742 
HIV CO INFECTION 72 
PREVALENCE 9.7% 
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In our study the the maximum distribution was seen in age group of more 
than  60 months (61.1%). 
SEXWISE DISTRIBUTION OF TUBERCULOSIS 
Sex Frequency Percent 
Male 46 63.9 
Female 26 36.1 
Total 72 100 
 
SEXWISE FREQUENCY OF TUBERCULOSIS 
46
26
Male
Female
 
In our study the maximum distribution is among the male children 
(63.9%) than female children(36.1%)
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CLINICAL MANIFESTATIONS 
Clinical Features 
Frequency Percent 
Yes No Total Yes No Total
Fever 72 - 72 100 - 100 
Cough 64 8 72 88.9 11.1 100 
Weight loss 62 10 72 86.1 13.9 100 
History of contact 
with open TB 
33 39 72 45.8 54.2 100 
Neck Swelling 27 45 72 37.5 62.5 100 
BCG 26 46 72 36.1 63.9 100 
Breathlessness 21 51 72 29.2 70.8 100 
Chest pain 15 57 72 20.8 79.2 100 
Vomiting / Nausea 4 68 72 5.6 94.4 100 
Seizures 4 68 72 5.6 94.4 100 
ALOC 3 69 72 4.2 95.8 100 
Diarrhoea / 
Constipation 
1 71 72 1.4 98.6 100 
Bone pain 1 71 72 1.4 98.6 100 
Abdominal Pain 1 72 72 1.4 98.6 100 
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FREQUENCY OF CLINICAL MANIFESTATIONS: 
 
72
64
62
33
27
26
21
15
4
4
3
1
1
1
0 10 20 30 40 50 60 70 80
Fever
Cough
Weight loss
History of contact with open TB
Neck Swelling
BCG
Breathlessness
Chest pain
Vomiting / Nausea
Seizures
ALOC
Diarrhoea / Constipation
Bone pain
Abdominal Pain
FREQUENCY
 
 
        In our study the most common clinical manifestation is fever (100%) 
and the least common symptom was abdominal pain(1.4%).
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TYPES OF TUBERCULOSIS IN CHILDREN COINFECTED 
WITH HIV 
Types of TB Frequency Percent 
Pulmonary 
Tuberculosis 
44 61.1 
Lymph node 
Tuberculosis 
22 30.6 
CNS Tuberculosis 4 5.6 
Abdominal 
Tuberculosis 
1 1.4 
Spine Tuberculosis 1 1.4 
Total 72 100 
 
FREQUENCY OF TYPES OF TUBERCULOSIS WITH HIV  
COINFECTION 
44
22
4 1 1
Pulmonary
Tuberculosis
Lymph node
Tuberculosis
CNS Tuberculosis
Abdominal
Tuberculosis
Spine Tuberculosis
 
In our study the most common type of TB was pulmonary TB in HIV/TB 
coinfection.  
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CD4 COUNT LEVEL 
 
Grade of 
Immunosuppression 
Frequency Percent 
Not significant 6 8.3 
Mild 34 47.2 
Advanced 30 41.7 
Severe 2 2.8 
Total 72 100 
 
 
 
6
34
30
2
0
10
20
30
40
Not
significant
Mild Advanced Severe
Grade of Immunosuppression
Fr
eq
ue
nc
y
 
In our study 41.7% of HIV-TB co infected children were in the 
advanced stage of immunosuppression. 
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TUBERCULOSIS TYPE & CD4 LEVEL CORRELATION 
 
 
Types of 
Tuberculosis 
 
CD4 
 
 
Total 
 Not 
significant
Mild Advanced Severe 
Pul TB  No. 
%  of Total 
3 
6.8% 
20 
45.5%
19 
43.2% 
2 
4.5% 
44 
100% 
Lym TB  No. 
% of Total 
2 
9.1% 
11 
50% 
9 
40.9% 
 22 
100% 
CNS TB  No. 
% of Total 
  1         
25% 
3      
75% 
4 
100% 
Abd TB   No. 
% of Total 
  1 
100% 
 1 
100% 
Spine TB   No. 
% of Total 
   1 
100% 
1 
100% 
Total 
 
5  
6.9% 
31 
43% 
30  
42% 
6  
8.1% 
72 
100% 
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CD4 CORRELATION WITH TYPE OF TUBERCULOSIS 
 
 
 
 
 
 
 
CD4 Count 
 
 
 
Pulmonary
TB 
 
 
 
Lympnode
TB 
 
 
 
CNS 
TB 
 
 
 
Abdominal
TB 
 
 
 
Spinal 
TB 
 
 
 
Total
 
Not 
Significant 
3 
60% 
2 
40% 
 
- - - 
 
5 
100%
 
Mild 20 
64.5% 
11 
35.5% - - - 
 
31 
100%
 
Advanced 19 
63.3% 
9 
30% 
1 
3.3% 
1 
3.3% - 
 
30 
100%
 
Severe 2 
33.3% - 
3 
50% - 
1 
16.7% 
 
6 
100%
Total 44 
61% 
22 
30% 
4 
5.5% 
1 
1.75% 
1 
1.75% 
 
72 
100%
                    
                                            p value is 0.04. 
In our study  CNS, abdominal & spinal tuberculosis were seen only in 
advanced and severe grade of immuno suppression. 
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DISTRIBUTION OF PULMONARY TB IN RELATION TO 
IMMUNOSUPPRESSION 
Pulmonary TB
3
20 19
2
0
5
10
15
20
25
Not
Significant
Mild Advanced Severe
Not Significant
Mild
Advanced
Severe
 
DISTRIBUTION OF LYMPHNODE TB IN RELATION TO 
IMMUNOSUPPRESSION
Lymphnode TB
2
11
9
0
0
2
4
6
8
10
12
Not significant Mild Advanced Severe
Not significant
Mild
Advanced
Severe
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DISTRIBUTION OF CNS TB IN RELATION TO 
IMMUNOSUPPRESSION 
CNS TUBERCULOSIS 
0 0
1
3
0
0.5
1
1.5
2
2.5
3
3.5
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
 
 
DISTRIBUTION OF ABDOMINAL TB IN RELATION TO 
IMMUNOSUPPRESSION 
Abdominal TB
0 0
1
0
0
0.2
0.4
0.6
0.8
1
1.2
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
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DISTRIBUTION OF SPINE TB IN RELATION TO 
IMMUNOSUPPRESSION 
Spine TB 
0 0 0
1
0
0.2
0.4
0.6
0.8
1
1.2
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
 
DISTRIBUTION OF TOTAL NO. OF HIV/TB COINFECTED 
CASES IN RELATION TO IMMUNO SUPPRESSION 
Total
5
31 30
6
0
5
10
15
20
25
30
35
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
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AGE & TUBERCULOSIS TYPE 
 
AGE 
 
TB Type 
 
Total 
Pul 
TB 
Lym 
TB 
Abd 
TB 
CNS 
TB 
Spine 
TB 
12 – 35 months No. 
% of total 
3 
42.9% 
4 
57.1% 
 
   7 
100% 
 
36-59 months   No. 
% of total 
11 
52.4% 
9 
42.9% 
  1 
4.8% 
21 
100% 
>60 months  No. 
% of total 
30 
68.2% 
 
9 
20.5% 
1 
2.3% 
4 
9.1% 
 44 
100% 
Total  No. 
% of total 
44 
61.1% 
22 
30.6% 
1 
1.4% 
4 
5.6% 
1 
1.4% 
72 
100% 
 
 
In our study, both pulmonary TB as well CNS TB occurred more 
commonly in children aged more than 60 months of age. 
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DISTRIBUTION OF TUBERCULOSIS TYPE IN AGE <35 
MONTHS 
Age <35 Months
42.90%
57.10%
Pul TB Lym TB Abd TB CNS TB Spine TB
Pul TB
Lym TB
Abd TB
CNS TB
Spine TB
 
 
DISTRIBUTION OF TUBERCULOSIS TYPE IN 
AGE 36 - 59 MONTHS  
Age 36 - 59 Months
52.40%
42.90%
4.80%
Pul TB Lym TB Abd TB CNS TB Spine TB
Pul TB
Lym TB
Abd TB
CNS TB
Spine TB
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DISTRIBUTION OF TUBERCULOSIS TYPE IN  
AGE ≥ 60 MONTHS  
≥ 60 Months
68.20%
20.50%
2.30%
9.10%
Pul TB Lym TB Abd TB CNS TB Spine TB
Pul TB
Lym TB
Abd TB
CNS TB
Spine TB
 
 
AGEWISE DISTRIBUTION OF TOTAL NO. OF HIV/TB 
COINFECTED CASES WITH TYPES OF TB 
 
Total
61.10%
30.60%
1.40%
5.60%
1.40%
Pul TB Lym TB Abd TB CNS TB Spine TB
Pul TB
Lym TB
Abd TB
CNS TB
Spine TB
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AGE & CD4 LEVEL CORRELATION 
 
AGE 
CD4  
 
Total 
 
Not significant Mild Advanced Severe 
12-35 months   No. 
% of total 
 
 
3 
42.9% 
4 
57.1% 
 7 
100% 
36-59 months         No. 
% of total 
1 
4.8% 
9 
42.9% 
9 
42.9% 
2 
9.5% 
21 
100% 
>60 months      No. 
% of total 
3 
6.82% 
22 
50.0% 
16 
36.36% 
3 
6.82% 
44 
100% 
Total        No. 
% of total 
4 
5.55% 
34 
47.24%
29 
40.27% 
5 
6.94% 
72 
100% 
    
 
In our study about 87.58% of HIV-TB coinfected children presented in 
mild and advanced grade of immuno suppression  and about 61.11% of 
children presented were more than 60 months of age. 
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CD 4 COUNT IN 12-35 MONTHS OF HIV / TB COINFECTED 
CHILDREN  
 
12 - 35 Months
0
3
4
00
1
2
3
4
5
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
 
 
CD 4 COUNT IN 36-59 MONTHS OF HIV / TB COINFECTED 
CHILDREN  
 
36-59 Months
1
9 9
2
0
2
4
6
8
10
Not
significant
Mild Advanced Severe
Not significant
Mild
Advanced
Severe
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CD 4 COUNT IN >60 MONTHS OF HIV / TB CO INFECTED 
CHILDREN  
3
22
16
3
0
5
10
15
20
25
Not 
significant
Mild Advanced Severe
>60 Months
Not significant
Mild
Advanced
Severe
 
 
AGEWISE DISTRIBUTION OF TOTAL NO. OF HIV/TB 
COINFECTED CHILDREN WITH CD4 COUNT  
4
34
29
5
0
5
10
15
20
25
30
35
40
Not 
significant
Mild Advanced Severe
Total
Not significant
Mild
Advanced
Severe
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DISCUSSION 
 
 
PREVALENCE IN OUR STUDY: 
   
In our study, out of 742  children enrolled from October 2008 to 
October 2010 in TB clinic in Institute of Child Health and hospital for 
children, Egmore, Chennai , 72 children were HIV positive . 
This implies that 9.7% of tuberculous children were coinfected 
with HIV which can have a great impact on the morbidity & mortality 
and treatment outcome of these children.This is very low when compared 
to studies in South Africa where it was 45%.21  This is also higher than the 
5.12% in an Indian study22. This difference could be because of the 
probable difference in prevalence of HIV in the respective areas.  
However this is very similar to the study done in Agra, India 24  
which showed a sero prevalence rate of 8.51%. 
AGE DISTRIBUTION: 
In our study we have classified HIV/TB coinfected children into 
three groups according to WHO classification. The major chunk was in 
the age group of more than 5yrs (44%) in our study. This is different from 
other study22  which showed an increased prevalence in the age group of 
1-5 yrs of age. In the Agra study the highest prevalence was seen in the 
age group of 2-5 years24. 
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SEX DISTRIBUTION: 
In our study male children(63.9%) were more affected than female 
children(36.1%). A similar result was given in the Agra study 24 which 
showed a high distribution in male (85.61% ) than female child (17.39%). 
This may be due to the parental bias to care more for a male child than a 
female child in the lower socioeconomic groups who are the major  
people getting health care in our hospital. 
CLINICAL MANIFESTATIONS: 
In our study the most common manifestations in HIV/TB 
coinfected children are fever (100%), cough (88.9%), weight 
loss(86.1%). History of contact with a known pulmonary TB is seen only 
in 45.8% of the infected children. Neck swelling is seen in 27%  and 
breathlessness in 21% of children. BCG scar was present only in 36.1% 
of  the coinfected children. Abdominal symptoms were present in 7% and 
CNS manifestations like seizures and ALOC were seen in 9.8% of 
patients. 
Since pulmonary tuberculosis is the most common type seen in our 
study, cough was the predominant specific symptom. 
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    TYPES OF TUBERCULOSIS: 
In our study pulmonary TB was the most common tuberculosis 
type(61.1%) followed by lymphatic TB (30.6%). CNS tuberculosis was 
next (5.6%)  and abdominal and spinal TB had a share of 1.4% each. 
Overall 39.9% of HIV/TB co infected children had extra 
pulmonary TB . In the Agra study24  a similar pattern of distribution with 
more pulmonary( 86.75%) than extra pulmonary TB (13.4%)  was found. 
CD4 COUNT IN HIV/TB COINFECTED CHILDREN: 
          In our study 47.2% of the co infected children had mild grade of 
immunosuppression and 41.7% had advanced grade of 
immunosuppression.  
    Only 8.3% of  the coinfected children had a CD4 count level which is 
not significant. 
CD4 COUNT CORRELATION WITH TYPES OF TB: 
In this study, pulmonary TB is more common in mild grade of 
immunosuppression(45.5%) than in advanced grade(43.2%) of immuno 
suppression.  
Lymphatic TB is more common in mild grade of immuno 
suppression(50%) followed by advanced (40.9%) grade of 
immunosuppression. 
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CNS (75%) and spinal (100%) TB are present only in severe grade 
of immuno suppression.  
Abdominal TB is seen in advanced grade of immuno suppression. 
Similarly  pulmonary TB is the most common type in not 
significant (60%), mild (64.5%) and advanced grade (63.3%) of 
immunosuppression. 
CNS TB is the most common TB (60%)  in severe  grade of 
immuno suppression. 
The P value is 0.04 and is significant. 
 AGE AND TUBERCULOSIS TYPE: 
In our study in children less than 35 months lymphatic TB is the 
most common type (57.1%). In children between 36-59 months of age 
pulmonary TB is more common ( 52.4%) and in children more than 60 
months of age pulmonary TB is the most predominant  (68.2%)type. 
CNS TB occurred only in children more than 60 months of age 
(100%). 
 AGE AND CD4 LEVEL CORRELATION: 
In this study 57.1% of children under 35 months had advanced 
grade of immunosuppression. 86% of children between 36 to 59 months 
had mild and advanced grade of immuno suppression and 50% of 
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children more than 60 months of age had mild grade of immuno 
suppression. 
LIMITATIONS OF STUDY 
 
 
1. The study is done in a tertiary care centre hence the same 
prevalence need not be true at the community level. 
2. This study is done only for a period of 2 years. 
3. CD4 count is not done for all tuberculosis patients.  
4. Outcome of these HIV/TB co infected individuals was not studied. 
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CONCLUSION 
 
1. The  HIV  prevalence rate among tuberculous children in our study 
is 9.7%. 
2. Hence  screening of all newly diagnosed tuberculous  children  for 
HIV coinfection  can be undertaken as a routine . 
3. Pulmonary TB is the most common type of TB in HIV/TB  
coinfection in our study. 
4. Pulmonary TB is the most common type in not significant , mild  
and advanced grade of immuno suppression. 
5. CNS tuberculosis is the most common type in severe grade of 
immuno suppression. 
6. CNS TB occurred more commonly in children more than 60 
months of age. 
7. Lymphnode TB is the commonest type of tuberculosis in children 
with HIV coinfection less than 35 months of age. 
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ANNEXURE 
 ANNEXURE – I 
 
PROFORMA 
 
Name:     Age:   Sex: 
Address:     Wt:   Height: 
 
S.No Clinical Features Yes No Duration 
1 Fever    
2 Cough    
3 Breathlessness    
4 Weight loss    
5 Chest pain    
6 History of contact with 
open TB 
   
7 Neck Swelling    
8 Abdominal Pain    
9 Abdominal Distention    
10 Vomiting / Nausea    
11 
 
Diarrhoea / 
Constipation 
   
12 Bleeding per rectum    
 13 Jaundice    
14 Bone pain    
15 Visual loss    
16 Seizures    
17 ALOC    
18 Dysuria / Hematuria    
19 Flank pain    
20 BCG    
21 Bony swelling    
 
Examination: 
 
General Examination: 
 
CVS 
Vitals  : 
Pulse  : 
Heart Rate: 
BP: 
RS 
 
P/A 
 
 
CNS 
 
 Lab Investigation: 
 Blood: 
HB 
TC 
DC 
ESR 
 LFT 
 Urine Microscopy 
 Mantoux 
 RGJ / Sputum Examination: 
 Chest x-ray 
 Parentral Screening 
 Biopsy / FNAC 
 USG Abdomen 
 Barium Meal / Enema 
  Bronchoscopy: BAL for Bactec,  
  Quantiferon Assay   
  CT    Chest 
          Brain 
         Abdomen 
 ELISA 
 PCR ASSAY 
 CD4 Cell Count 
  
